Menu

Blog

Jun 14, 2024

BRAF-Targeted Drug Approved for Pediatric Low-Grade Glioma

Posted by in category: biotech/medical

FDA has granted an accelerated approval to tovorafenib (Ojemda) for kids and teens who have low-grade glioma with changes in the BRAF gene.

Leave a reply